Kidney international最新文献

筛选
英文 中文
Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL Study. 在EQUAL研究中通过g公式分析CKD- mbd生物标志物改变对CKD进展的因果评估。
IF 19.6 1区 医学
Kidney international Pub Date : 2025-09-09 DOI: 10.1016/j.kint.2025.07.032
Lorenza Magagnoli,Mario Cozzolino,Fergus J Caskey,Claudia Torino,Friedo W Dekker,Marie Evans,Maciej Szymczak,Christoph Wanner,Maria Pippias,Christiane Drechsler,Antonio Vilasi,Esmee Driehuis,Peter Stenvinkel,Vianda S Stel,Kitty J Jager,Nicholas C Chesnaye,
{"title":"Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL Study.","authors":"Lorenza Magagnoli,Mario Cozzolino,Fergus J Caskey,Claudia Torino,Friedo W Dekker,Marie Evans,Maciej Szymczak,Christoph Wanner,Maria Pippias,Christiane Drechsler,Antonio Vilasi,Esmee Driehuis,Peter Stenvinkel,Vianda S Stel,Kitty J Jager,Nicholas C Chesnaye, ","doi":"10.1016/j.kint.2025.07.032","DOIUrl":"https://doi.org/10.1016/j.kint.2025.07.032","url":null,"abstract":"INTRODUCTIONChronic Kidney Disease - Mineral and Bone Disorder (CKD-MBD) may both be a cause and a consequence of CKD progression. Here, we examine the individual and joint effect of longitudinal circulating phosphate, parathyroid hormone, and calcium levels on estimated glomerular filtration rate (eGFR) decline, the risk of starting dialysis and the composite risk of death or dialysis, in a cohort of elderly patients with advanced CKD not on dialysis. Secondly, we explore whether these effects differ between men and women.METHODSWe used data from 1709 participants in the European Quality study, which includes patients aged 65 and older with eGFR 20 ml/min per 1.73m2 or less from six European countries. To avoid bias due to informative censoring, competing risks and time-varying confounding, we used the g-formula for causal inference.RESULTSIsolated hyperphosphatemia and hyperparathyroidism were associated with a higher risk of CKD progression, whereas isolated hypercalcemia was not. The combination of hyperphosphatemia with hyperparathyroidism, and of hypocalcemia with hyperparathyroidism were also associated with significantly higher risk. The most adverse phenotype was the combination of hyperphosphatemia, hypocalcemia and hyperparathyroidism, which led to a mean difference in eGFR after three years of -3.71 ml/min (95% confidence intervals: -5.44, -2.15) and a 75% higher risk of starting dialysis (hazard ratio 1.75, 95% confidence interval 1.35-2.10), compared to having all biomarkers in their reference ranges. Most of this risk was attributable to hyperphosphatemia. Although the effect of abnormal mineral biomarkers on eGFR decline was similar between sexes, the associated risk of starting dialysis seemed stronger in men than in women.CONCLUSIONAmong older men and women with advanced CKD not receiving dialysis, the presence of hyperphosphatemia, especially when combined with hypocalcemia and hyperparathyroidism, leads to an increased risk of CKD progression.","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"41 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145035801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis. 一种较强的I型干扰素特征可以区分anca相关的血管炎表型并预测肾脏预后。
IF 19.6 1区 医学
Kidney international Pub Date : 2025-09-09 DOI: 10.1016/j.kint.2025.07.034
Benoît Brilland,Maïa Despré,Robin Khatri,Thomas Quéméneur,Cyrille Vandenbussche,Nathalie Merillon,Andrea Boizard-Moracchini,Maëva Roy,Laurence Preisser,Jérémie Riou,Giorgina Barbara Piccoli,Assia Djema,Nicolas Henry,Odile Blanchet,Stefan Bonn,Céline C Berthier,Peter Grayson,Yves Delneste,Viviane Gnemmi,Patrick Blanco,Marie-Christine Copin,David Langlais,Jean-François Augusto,
{"title":"A stronger type I interferon signature distinguishes ANCA-associated vasculitis phenotypes and predicts kidney prognosis.","authors":"Benoît Brilland,Maïa Despré,Robin Khatri,Thomas Quéméneur,Cyrille Vandenbussche,Nathalie Merillon,Andrea Boizard-Moracchini,Maëva Roy,Laurence Preisser,Jérémie Riou,Giorgina Barbara Piccoli,Assia Djema,Nicolas Henry,Odile Blanchet,Stefan Bonn,Céline C Berthier,Peter Grayson,Yves Delneste,Viviane Gnemmi,Patrick Blanco,Marie-Christine Copin,David Langlais,Jean-François Augusto, ","doi":"10.1016/j.kint.2025.07.034","DOIUrl":"https://doi.org/10.1016/j.kint.2025.07.034","url":null,"abstract":"INTRODUCTIONAnti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) causes severe multisystemic organ damage. The main phenotypes, microscopic polyangiitis (MPA) and granulomatosis with polyangiitis (GPA), share similarities but differ in clinical presentation and outcome. To uncover their molecular differences, we performed transcriptomic profiling of kidney tissue, then focused on type I interferon (IFN-I) pathway activation in kidney and blood and its clinical implications.METHODSWe analyzed two independent cohorts (Maine-Anjou and RENVAS registries) totaling 193 patients with AAV and glomerulonephritis. NanoString nCounter transcriptomic profiling, and serum inflammatory molecules quantification were conducted. Comparative analyses of MPA vs. GPA (and MPO-AAV vs. PR3-AAV) were validated using independent public datasets (including kidney spatial transcriptomic datasets, European cDNA Renal Biobank and blood from the RAVE trial).RESULTSThe kidney IFN-I signature found in AAV-GN is upregulated in MPA/MPO-AAV compared to GPA/PR3-AAV and controls. Quantitative PCR, MxA immunohistochemistry, and analysis of external datasets confirmed these findings. This IFN-I signature, close to the one found in lupus nephritis, is linked to the extent of pDC infiltration. Kidney IFN-I activation correlated with increased kidney fibrosis, independently of kidney function. High kidney IFN-I signatures were linked to lower kidney survival, independently of kidney function and pathological scores. MPA kidneys also exhibited higher mast cell and T cell infiltration. Systemic analyses showed elevated IFNα and interferon related inflammatory molecules in all patients with AAV, but a stronger IFN-I gene signature was found in immune cells from MPA.CONCLUSIONOur study identifies an IFN-I signature in AAV, especially in MPA/MPO-AAV, underscoring its potential role in disease heterogeneity and kidney pathology. IFN-I emerges as a potential prognostic biomarker and therapeutic target in AAV, particularly for MPA. Further studies are needed to clarify its mechanisms and explore IFN-I modulation in clinical trials.","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"170 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145035803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Felzartamab: a magic bullet to treat microvascular rejection? 非扎他抗:治疗微血管排斥反应的灵丹妙药?
IF 19.6 1区 医学
Kidney international Pub Date : 2025-09-08 DOI: 10.1016/j.kint.2025.06.023
Olivier Thaunat,Robert B Colvin
{"title":"Felzartamab: a magic bullet to treat microvascular rejection?","authors":"Olivier Thaunat,Robert B Colvin","doi":"10.1016/j.kint.2025.06.023","DOIUrl":"https://doi.org/10.1016/j.kint.2025.06.023","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"56 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145018199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Out of chaos, comes tolerance: targeting the T cells driving antibody-mediated rejection. 从混乱中产生了耐受性:以T细胞为目标,驱动抗体介导的排斥反应。
IF 19.6 1区 医学
Kidney international Pub Date : 2025-09-08 DOI: 10.1016/j.kint.2025.07.017
Griffith B Perkins,P Toby Coates,Robert L Fairchild
{"title":"Out of chaos, comes tolerance: targeting the T cells driving antibody-mediated rejection.","authors":"Griffith B Perkins,P Toby Coates,Robert L Fairchild","doi":"10.1016/j.kint.2025.07.017","DOIUrl":"https://doi.org/10.1016/j.kint.2025.07.017","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"130 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145018200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual dimorphism of age and nephron segment specific gene expression in mouse kidneys: insights from multi-omic and spatial analysis. 小鼠肾脏中年龄和肾单元段特异性基因表达的性别二态性:来自多组学和空间分析的见解。
IF 19.6 1区 医学
Kidney international Pub Date : 2025-09-08 DOI: 10.1016/j.kint.2025.07.014
Anita T Layton
{"title":"Sexual dimorphism of age and nephron segment specific gene expression in mouse kidneys: insights from multi-omic and spatial analysis.","authors":"Anita T Layton","doi":"10.1016/j.kint.2025.07.014","DOIUrl":"https://doi.org/10.1016/j.kint.2025.07.014","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"35 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145018005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EPO and tumor growth: the key is immunosuppression. EPO与肿瘤生长:关键是免疫抑制。
IF 19.6 1区 医学
Kidney international Pub Date : 2025-09-05 DOI: 10.1016/j.kint.2025.07.013
Kai-Uwe Eckardt
{"title":"EPO and tumor growth: the key is immunosuppression.","authors":"Kai-Uwe Eckardt","doi":"10.1016/j.kint.2025.07.013","DOIUrl":"https://doi.org/10.1016/j.kint.2025.07.013","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"28 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144995717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Albuminuria-based universal screening for CKD should be implemented now in high income countries. 现在应该在高收入国家实施以蛋白尿为基础的CKD普遍筛查。
IF 19.6 1区 医学
Kidney international Pub Date : 2025-08-28 DOI: 10.1016/j.kint.2025.04.037
Lucia Cordero,Alberto Ortiz
{"title":"Albuminuria-based universal screening for CKD should be implemented now in high income countries.","authors":"Lucia Cordero,Alberto Ortiz","doi":"10.1016/j.kint.2025.04.037","DOIUrl":"https://doi.org/10.1016/j.kint.2025.04.037","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"61 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144995707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Universal screening for CKD…Just because we can do it should we do it? 就因为我们能做,我们就应该做吗?
IF 19.6 1区 医学
Kidney international Pub Date : 2025-08-27 DOI: 10.1016/j.kint.2025.08.004
Brad H Rovin
{"title":"Universal screening for CKD…Just because we can do it should we do it?","authors":"Brad H Rovin","doi":"10.1016/j.kint.2025.08.004","DOIUrl":"https://doi.org/10.1016/j.kint.2025.08.004","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"39 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144995711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To screen or not to screen: why universal CKD testing isn't a goer! 筛查还是不筛查:为什么普遍的CKD检测不可行!
IF 19.6 1区 医学
Kidney international Pub Date : 2025-08-27 DOI: 10.1016/j.kint.2025.05.040
Germaine Wong,Anita van Zwieten
{"title":"To screen or not to screen: why universal CKD testing isn't a goer!","authors":"Germaine Wong,Anita van Zwieten","doi":"10.1016/j.kint.2025.05.040","DOIUrl":"https://doi.org/10.1016/j.kint.2025.05.040","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"304 1","pages":""},"PeriodicalIF":19.6,"publicationDate":"2025-08-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144995718","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distal renal tubular alkalosis: a mirror image of distal renal tubular acidosis? 远端肾小管碱中毒:远端肾小管酸中毒的镜像?
IF 12.6 1区 医学
Kidney international Pub Date : 2025-08-26 DOI: 10.1016/j.kint.2025.07.007
Nabil William G Sweis, Daniel Batlle
{"title":"Distal renal tubular alkalosis: a mirror image of distal renal tubular acidosis?","authors":"Nabil William G Sweis, Daniel Batlle","doi":"10.1016/j.kint.2025.07.007","DOIUrl":"https://doi.org/10.1016/j.kint.2025.07.007","url":null,"abstract":"","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":" ","pages":""},"PeriodicalIF":12.6,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144959319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信